Lei Fan,Wu Du,Xinghai Li,Yuanwei Chen,Kexin Xu,Ke Chen,Shaohua Zhang,Tongchuan Luo
申请号：
US15781997
公开号：
US10450274B2
申请日:
2016.12.06
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Quinoline compounds and salts, hydrates or solvates serving as a selective uric acid reabsorption inhibitor, can be used in the treatment of hyperuricemia and gout by promoting uric acid to excrete from the body and reducing serum uric acid. Such compounds have the effect of reducing the uric acid in the animal body and human body.
